Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Walter

Showing results (51-60 of 106) with videos related to

Pageof 11
Sort By:
The Journal of Molecular Diagnostics : JMD|September 28, 2025
Evaluation of Long-Read Genome Sequencing for Genomic Profiling of Myeloid CancersHaley J Abel, Mohamed Mahgoub, Nidhi Davarapalli, et al.
Leukemia|March 16, 2023
Impact of U2AF1 mutations on circular RNA expression in myelodysplastic neoplasmsEileen Wedge, Ulvi Ahmadov, Thomas B Hansen, et al.
Plos Computational Biology|August 8, 2014
SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolutionChristopher A Miller, Brian S White, Nathan D Dees, et al.
Cancer Cell|May 13, 2015
Mutant U2AF1 Expression Alters Hematopoiesis and Pre-mRNA Splicing In VivoCara Lunn Shirai, James N Ley, Brian S White, et al.
Blood Advances|February 24, 2026
Exposure to Agent Orange and Association with Myelodysplastic SyndromesMikkael A Sekeres, Amy E DeZern, Michael Otterstatter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 6, 2024
Plasma Proteomic Signature Predicts Myeloid Neoplasm RiskDuc Tran, J Scott Beeler, Jie Liu, et al.
Cancer Research|July 3, 2021
Nonsense-Mediated RNA Decay Is a Unique Vulnerability of Cancer Cells Harboring <i>SF3B1</i> or <i>U2AF1</i> MutationsAbigael Cheruiyot, Shan Li, Sridhar Nonavinkere Srivatsan, et al.
Cancer Cell|March 12, 2014
Functional heterogeneity of genetically defined subclones in acute myeloid leukemiaJeffery M Klco, David H Spencer, Christopher A Miller, et al.
Blood|December 4, 2015
Rapid expansion of preexisting nonleukemic hematopoietic clones frequently follows induction therapy for de novo AMLTerrence N Wong, Christopher A Miller, Jeffery M Klco, et al.
JCI Insight|March 9, 2018
Subclones dominate at MDS progression following allogeneic hematopoietic cell transplantMeagan A Jacoby, Eric J Duncavage, Gue Su Chang, et al.
Pageof 11

Showing results (51-60 of 106) with videos related to

Sort By:
Pageof 11
The Journal of Molecular Diagnostics : JMD|September 28, 2025
Evaluation of Long-Read Genome Sequencing for Genomic Profiling of Myeloid CancersHaley J Abel, Mohamed Mahgoub, Nidhi Davarapalli, et al.
Leukemia|March 16, 2023
Impact of U2AF1 mutations on circular RNA expression in myelodysplastic neoplasmsEileen Wedge, Ulvi Ahmadov, Thomas B Hansen, et al.
Plos Computational Biology|August 8, 2014
SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolutionChristopher A Miller, Brian S White, Nathan D Dees, et al.
Cancer Cell|May 13, 2015
Mutant U2AF1 Expression Alters Hematopoiesis and Pre-mRNA Splicing In VivoCara Lunn Shirai, James N Ley, Brian S White, et al.
Blood Advances|February 24, 2026
Exposure to Agent Orange and Association with Myelodysplastic SyndromesMikkael A Sekeres, Amy E DeZern, Michael Otterstatter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 6, 2024
Plasma Proteomic Signature Predicts Myeloid Neoplasm RiskDuc Tran, J Scott Beeler, Jie Liu, et al.
Cancer Research|July 3, 2021
Nonsense-Mediated RNA Decay Is a Unique Vulnerability of Cancer Cells Harboring <i>SF3B1</i> or <i>U2AF1</i> MutationsAbigael Cheruiyot, Shan Li, Sridhar Nonavinkere Srivatsan, et al.
Cancer Cell|March 12, 2014
Functional heterogeneity of genetically defined subclones in acute myeloid leukemiaJeffery M Klco, David H Spencer, Christopher A Miller, et al.
Blood|December 4, 2015
Rapid expansion of preexisting nonleukemic hematopoietic clones frequently follows induction therapy for de novo AMLTerrence N Wong, Christopher A Miller, Jeffery M Klco, et al.
JCI Insight|March 9, 2018
Subclones dominate at MDS progression following allogeneic hematopoietic cell transplantMeagan A Jacoby, Eric J Duncavage, Gue Su Chang, et al.
Pageof 11